Induet Tablet 5mg/20mg
Atorvastatin Calcium 20.72mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
INTROBIOPHARMA Co., Ltd.
MFDS item code 201603397 · Approved 2016.06.13
Treatment of hypertension and angina, improvement of dyslipidemia, and prevention of cardiovascular disease
This medication is used in patients who require simultaneous administration of amlodipine and atorvastatin. Amlodipine is effective in treating hypertension and stable or variant angina due to myocardial ischemia, and helps to reduce the risk of angina related to coronary artery disease in patients who are not in heart failure. Atorvastatin reduces the risk of myocardial infarction, stroke, and vascular surgery in patients with multiple cardiovascular risk factors, especially those with type 2 diabetes and coronary artery disease. Additionally, this medication is used in the treatment of primary hypercholesterolemia and dyslipidemia, reducing blood cholesterol and triglycerides while increasing HDL cholesterol to improve cardiovascular health. It is effectively used for reducing cardiovascular disease risk and improving dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine/atorvastatin. Amlodipine (S-amlodipine) Adults: Administer amlodipine (S-amlodipine) 5(2.5) mg orally once daily; the dose may be increased to a maximum of 10(5) mg once daily depending on the patient's response. Adjust the dose as appropriate according to symptoms. Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at doses ranging from 10 mg ∼ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ∼ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. 3. Patients with renal impairment Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. 4. Older adults Efficacy and safety in older adults aged 70 years or older are generally similar to those in the general adult patient population.
This medication should not be used in certain patients. For instance, it should not be administered to patients who have allergies to this drug or similar medications, those with severely impaired liver function, pregnant or breastfeeding women, patients with muscular disorders, patients with severe aortic stenosis, or those in a state of shock, as well as patients within one month after a myocardial infarction. In addition, patients with severely impaired kidney function, the elderly, alcoholics, or those with a history of liver disease, and patients who are at high risk of muscle injury should be given this medication with caution. These patients should periodically check their condition through blood tests before and during medication administration. This medication is primarily used to control blood pressure and cholesterol levels and is generally well-tolerated. However, rare side effects such as skin rashes, myalgia, gastrointestinal disturbances, headache, and dizziness may occur, and patients should consult a physician immediately if symptoms appear. Especially, if symptoms like myalgia, muscle weakness, or muscle cramps occur, it may indicate serious muscle damage, so it is important to inform healthcare professionals immediately. If symptoms of liver dysfunction (e.g., jaundice, fatigue, nausea, etc.) occur, the medication should be discontinued, and the patient should consult a physician. This medication may interact with other drugs; therefore, if the patient is currently taking any medications, it is essential to inform healthcare professionals. Special caution should be taken when co-administering with certain antibiotics, antifungals, immunosuppressants, specific antiviral agents, and grapefruit juice, as these can alter drug concentration. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be immediately discontinued and discussed with healthcare professionals. It is also recommended that breastfeeding women discontinue breastfeeding while taking this medication. The safety and efficacy of this medication in children and the elderly have not been sufficiently established; therefore, special precautions are necessary in these age groups. In cases of overdose, serious symptoms such as hypotension and heart function deterioration may occur, so the patient should seek appropriate treatment from a medical institution immediately. Lastly, this medication should be kept out of reach of children, and transferring it to other containers is not recommended for safety and quality maintenance.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature between 15 and 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent deterioration.
White oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium 20.72mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
INTROBIOPHARMA Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatriss Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 21.7mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatrise Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 43.4mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatris Korea Co., Ltd.
CombinationAtorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Atorvastatin Calcium Trihydrate 10.36mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationAtorvastatin Calcium 20.72mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationAtorvastatin Calcium 10.36mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.